Diagnostic approach to hereditary ataxias in Peru
DOI:
https://doi.org/10.20453/rnp.v89i1.6254Keywords:
hereditary ataxias, diagnosis, differential diagnosis, spinocerebellar ataxias, spinocerebellar degenerationsAbstract
Hereditary ataxias represent a diverse group of neurogenetic disorders characterized by impairments in motor coordination due to dysfunction of the cerebellum or its associated pathways. These diseases include autosomal dominant, recessive, X-linked, and mitochondrial forms. The diagnosis and management of hereditary ataxias are complex and face additional challenges in resource-limited regions such as Peru and other Latin American countries. This review proposes a structured diagnostic approach for hereditary ataxias based on five key pillars: (1) confirmation of the type of ataxia (cerebellar or non-cerebellar), (2) age of onset, (3) mode of presentation (predominantly pure or plus), (4) family history, and (5) exclusion of reversible or secondary causes. The most useful ancillary test/procedures for differential diagnosis depending on the information from the 5 axes include serum analyses, neuroimaging, neurophysiological studies, neuro-ophthalmological evaluations, vestibular testing, and genetic studies (specific gene testing, genetic panels, exome sequencing, and clinical genome analysis). Implementing a diagnostic approach based on these pillars optimizes both the diagnosis and clinical management of hereditary ataxias, especially in resource-limited settings.
Downloads
References
Kuo SH. Ataxia. Continuum. 2019;25(4):1036-54. doi:10.1212/con.0000000000000753
Pilotto F, Del Bondio A, Puccio H. Hereditary ataxias: from bench to clinic, where do we stand? Cells. 2024;13(4):319. doi:10.3390/cells13040319
Scott SS, Pedroso JL, Barsottini OG, et al. Natural history and epidemiology of the spinocerebellar ataxias: insights from the first description to nowadays. J Neurol Sci. 2020;417:117082. doi:10.1016/j.jns.2020.117082
Lima M, Raposo M, Ferreira A, et al. The homogeneous Azorean Machado-Joseph disease cohort: characterization and contributions to advances in research. Biomedicines. 2023;11(2):247. doi:10.3390/biomedicines11020247
Sena LS, Furtado GV, Pedroso JL, et al. Spinocerebellar ataxia type 2 has multiple ancestral origins. Parkinsonism Relat Disord. 2024;120:105985. doi:10.1016/j.parkreldis.2023.105985
Galecio-Castillo M, Gutierrez-Arratia J, Abad-Murillo A, et al. Epidemiology of autosomal dominant spinocerebellar ataxias in Latin America: a systematic review and meta-analysis. Cerebellum. 2025;24:75. doi:10.1007/s12311-025-01826-x
Novis LE, Frezatti RS, Pellerin D, et al. Frequency of GAA- FGF14 ataxia in a large cohort of Brazilian patients with unsolved adult-onset cerebellar ataxia. Neurol Genet. 2023;9(5):e200094. doi:10.1212/NXG.000000000020009
Pellerin D, Danzi MC, Wilke C, et al. Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med. 2023;388(2):128-41. doi:10.1056/NEJMoa2207406
Ando M, Higuchi Y, Yuan J, et al. Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan. Ann Clin Transl Neurol. 2024;11(1):96-104. doi:10.1002/acn3.51936
Rafehi H, Read J, Szmulewicz DJ, et al. An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14. Am J Hum Genet. 2023;110(1):105-19. doi:10.1016/j.ajhg.2022.11.015
Pellerin D, Danzi MC, Renaud M, et al. Spinocerebellar ataxia 27B: a novel, frequent and potentially treatable ataxia. Clin Transl Med. 2024;14(1):e1504. doi:10.1002/ctm2.1504
Figueroa KP, Gross C, Buena-Atienza E, et al. A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy. Nat Genet. 2024;56:1080-9. doi:10.1038/s41588-024-01719-5
Tan D, Wei C, Chen Z, et al. CAG repeat expansion in THAP11 is associated with a novel spinocerebellar ataxia. Mov Disord. 2023;38(7):1282-93. doi:10.1002/mds.29412
Manto M, Gandini J, Feil K, et al. Cerebellar ataxias: an update. Curr Opin Neurol. 2020;33(1):150-60. doi:10.1097/WCO.0000000000000774
Pilotto F, Saxena S. Epidemiology of inherited cerebellar ataxias and challenges in clinical research. Clin Transl Neurosci. 2018;2(2):22. doi:10.1177/2514183x18785258
Bagaria J, Bagyinszky E, An SS. Genetics of autosomal recessive spastic ataxia of charlevoix-saguenay (ARSACS) and role of sacsin in neurodegeneration. Int J Mol Sci. 2022;23(1):552. doi:10.3390/ijms23010552
Zanni G, Bertini E. X-linked ataxias. Handb Clin Neurol. 2018;155:175-89. doi:10.1016/b978-0-444-64189-2.00011-1
Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, et al. Fragile X-associated tremor/ataxia syndrome (FXTAS): pathophysiology and clinical implications. Int J Mol Sci. 2020;21(12):4391. doi:10.3390/ijms21124391
Lopriore P, Ricciarini V, Siciliano G, et al. Mitochondrial ataxias: molecular classification and clinical heterogeneity. Neurol Int. 2022;14(2):337-56. doi:10.3390/neurolint14020028
Vernon HJ, Bindoff LA. Mitochondrial ataxias. Handb Clin Neurol. 2018;155:129-41. doi:10.1016/b978-0-444-64189-2.00009-3
Radmard S, Zesiewicz TA, Kuo SH. Evaluation of cerebellar ataxic patients. Neurol Clin. 2023;41(1):21-44. doi:10.1016/j.ncl.2022.05.002
Salari M, Etemadifar M, Rashedi R, et al. A review of ocular movement abnormalities in hereditary cerebellar ataxias. Cerebellum. 2024;23:702-21. doi:10.1007/s12311-023-01554-0
Zhang Q, Zhou X, Li Y, et al. Clinical recognition of sensory ataxia and cerebellar ataxia. Front Hum Neurosci. 2021;15:639871. doi:10.3389/fnhum.2021.639871
Ashizawa T, Xia G. Ataxia. Continuum. 2016;22(4):1208-26. doi:10.1212/CON.0000000000000362
Milletti D, Randi FT, Lanzino G, et al. Gait apraxia and Hakim’s disease: a historical review. Biomedicines. 2023;11(4):1086. doi:10.3390/biomedicines11041086
Cortese A, Curro R, Vegezzi E, et al. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects. Pract Neurol. 2022;22(1):14-8. doi:10.1136/practneurol-2020-002822
Schmitz-Hübsch T, Du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717-20. doi:10.1212/01.wnl.0000219042.60538.92
Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145(2):205-11. doi:10.1016/s0022-510x(96)00231-6
Kieling C, Rieder CR, Silva AC, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15(4):371-6. doi:10.1111/j.1468-1331.2008.02078.x
Perez-Lloret S, van de Warrenburg B, Rossi M, et al. Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations. Mov Disord. 2021;36(2):283-97. doi:10.1002/mds.28313
Saute JA, Donis KC, Serrano-Munuera C, et al. Ataxia rating scales-psychometric profiles, natural history and their application in clinical trials. Cerebellum. 2012;11:488-504. doi:10.1007/s12311-011-0316-8
Fernandez-Boccazzi JM, Eizaguirre B, Merchan-del-Hierro X, et al. Spanish translation and pilot validation of the scale for the assessment and rating of ataxia (SARA). JACN. 2025;6(2):1-13. doi:10.17981/JACN.6.2.2025.6654
Chen TX, Casey HL, Lin CY, et al. Early-life social determinants of SCA6 age at onset, severity, and progression. Cerebellum. 2024;23:1449-56. doi:10.1007/s12311-023-01655-w
Novis LE, Silva TY, Pedroso JL, et al. Demystifying the Etiology of ILOCA in the Genomic Era: a narrative review. Cerebellum. 2025;24:45. doi:10.1007/s12311-025-01798-y
Barsottini OG, de Albuquerque MV, Braga-Neto P, et al. Adult onset sporadic ataxias: A diagnostic challenge. Arq Neuropsiquiatr. 2014;72(3):232-40. doi:10.1590/0004-282x20130242
Chaar [AT2.1]W, Eranki AN, Stevens HA, et al. Clinical, radiological and pathological features of a large american cohort of spinocerebellar ataxia (SCA27B). Ann Neurol. 2024;96(6):1092-103. doi:10.1002/ana.27060
Synofzik M, Németh AH. Recessive ataxias. Handb Clin Neurol. 2018;155:73-89. doi:10.1016/b978-0-444-64189-2.00005-6
Coarelli G, Wirth T, Tranchant C, et al. The inherited cerebellar ataxias: an update. J Neurol. 2023;270(1):208-22. doi:10.1007/s00415-022-11383-6
Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159. doi:10.1186/s13023-016-0543-7
Thapa S, Shah S, Chand S, et al. Ataxia due to vitamin E deficiency: a case report and updated review. Clin Case Rep. 2022;10(9):e6303. doi:10.1002/ccr3.6303
Duquette A, Brais B, Bouchard JP, et al. Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. Mov Disord. 2013;28(14):2011-4. doi:10.1002/mds.25604
Bras J, Alonso I, Barbot C, et al. Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet. 2015;96(3):474-9. doi:10.1016/j.ajhg.2015.01.005
Soong BW, Morrison PJ. Spinocerebellar ataxias. Handb Clin Neurol. 2018;155:143-74. doi:10.1016/b978-0-444-64189-2.00010-x
Raslan IR, Barsottini OG, Pedroso JL. A proposed clinical classification and a diagnostic approach for congenital ataxias. Neurol Clin Pract. 2021;11(3):e328-36. doi:10.1212/cpj.0000000000000966
Cerecedo-Zapata CM, Tapia-Guerrero YS, Ramírez-González JA, et al. Current overview of spinocerebellar ataxia type 7 in Mexican population: challenges in specialized care for a rare disease. Int J Mol Sci. 2024;25(19):10750. doi:10.3390/ijms251910750
Cornejo-Olivas M, Inca-Martinez M, Castilhos RM, et al. Genetic analysis of hereditary ataxias in Peru identifies sca10 families with incomplete penetrance. Cerebellum. 2020;19:208-15. doi:10.1007/s12311-019-01098-2
Sullivan R, Yau WY, O’Connor E, et al. Spinocerebellar ataxia: an update. J Neurol. 2019;266:533-44. doi:10.1007/s00415-018-9076-4
Zhang S, Shen L, Jiao B. Cognitive dysfunction in repeat expansion diseases: a review. Front Aging Neurosci. 2022;14:841711. doi:10.3389/fnagi.2022.841711
Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24. doi:10.1038/s41572-019-0074-3
Instituto Nacional de Ciencias Neurológicas (PE). Guía de práctica clínico-molecular para atención de ataxias hereditarias [Internet]. Lima: INCN; 2019. Disponible en: https://www.incn.gob.pe/guias-de-practica-clinica-y-consentimientos-informados/
Rossi M, Wainsztein N, Merello M. Cardiac involvement in movement disorders. Mov Disord Clin Pract. 2021;8(5):651-68. doi:10.1002/mdc3.13188
Mulroy E, Baschieri F, Magrinelli F, et al. Movement disorders and liver disease. Mov Disord Clin Pract. 2021;8(6):828-42. doi:10.1002/mdc3.13238
Takahashi M, Okazaki H, Ohashi K, et al. Current diagnosis and management of abetalipoproteinemia. J Atheroscler Thromb. 2021;28(10):1009-19. doi:10.5551/jat.rv17056
Nóbrega PR, Bernardes AM, Ribeiro RM, et al. Cerebrotendinous Xanthomatosis: a practice review of pathophysiology, diagnosis, and treatment. Front Neurol. 2022;13:1049850. doi:10.3389/fneur.2022.1049850
Nishino I, Ozawa E. Muscular dystrophies. Curr Opin Neurol. 2002;15(5):539-44. doi:10.1097/00019052-200210000-00004
Lipiński P, Tylki-Szymańska A. Congenital disorders of glycosylation: what clinicians need to know? Front Pediatr. 2021;9:715151. doi:10.3389/fped.2021.715151
Perez J, Zavala L, Vega P, et al. Overwhelming genetic heterogeneity and exhausting molecular diagnostic process in chronic and progressive ataxias: facing it up with an algorithm, a gene, a panel at a time. J Hum Genet. 2020;65:895-902. doi:10.1038/s10038-020-0785-z
Harel T, Pehlivan D, Caskey CT, et al. Mendelian, non-mendelian, multigenic inheritance, and epigenetics. En: Rosenberg RN, Pascual JM, editores. Rosenberg’s molecular and genetic basis of neurological and psychiatric disease. 5a. ed. San Diego: Elsevier; 2014. pp. 3-27. doi:10.1016/B978-0-12-410529-4.00001-2
Pedroso JL, Braga-Neto P, Abrahão A, et al. Article autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family. Arq Neuropsiquiatr. 2011;69(2B):288-91. doi:10.1590/s0004-282x2011000300004
Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med. 2013;15(9):673-83. doi:10.1038/gim.2013.28
Lieto M, Roca A, Santorelli FM, et al. Degenerative and acquired sporadic adult onset ataxia. Neurol Sci. 2019;40:1335-42. doi:10.1007/s10072-019-03856-w
Divya KP, Kishore A. Treatable cerebellar ataxias. Clin Park Relat Disord. 2020;3:100053. doi:10.1016/j.prdoa.2020.100053
Stezin A, Pal PK. Treatable ataxias: how to find the needle in the haystack? J Mov Disord. 2022;15(3):206-26. doi:10.14802/jmd.22069
Hassan A. Episodic ataxias: primary and secondary etiologies, treatment, and classification approaches. Tremor Other Hyperkinet Mov. 2023;13:9. doi:10.5334/tohm.747
Teive HA, Ashizawa T. Primary and secondary ataxias. Curr Opin Neurol. 2015;28(4):413-22. doi:10.1097/WCO.0000000000000227
De Silva RN, Vallortigara J, Greenfield J, et al. Diagnosis and management of progressive ataxia in adults. Pract Neurol. 2019;19(3):196-207. doi:10.1136/practneurol-2018-002096
De Silva R, Greenfield J, Cook A, et al. Guidelines on the diagnosis and management of the progressive ataxias. Orphanet J Rare Dis. 2019;14:51. doi:10.1186/s13023-019-1013-9
Schieving JH, De Vries M, Van Vugt JM, et al. Alpha-fetoprotein, a fascinating protein and biomarker in neurology. Eur J Paediatr Neurol. 2014;18(3):243-8. doi:10.1016/j.ejpn.2013.09.003
Ilg W, Branscheidt M, Butala A, et al. Consensus paper: neurophysiological assessments of ataxias in daily practice. Cerebellum. 2018;17:628-53. doi:10.1007/s12311-018-0937-2
Liang L, Chen T, Wu Y. The electrophysiology of spinocerebellar ataxias. Neurophysiol Clin. 2016;46(1):27-34. doi:10.1016/j.neucli.2015.12.006
Spina F, Sato MT, Shiokawa N, et al. Comparative optical coherence tomography study of spinocerebellar ataxia types 3 and 10. Cerebellum. 2017;16:797-801. doi:10.1007/s12311-017-0856-7
Parkinson MH, Bartmann AP, Clayton LMS, et al. Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Brain. 2018;141(4):989-99. doi:10.1093/brain/awy028
Maestre SJ, Santos D. Recomendaciones para el abordaje de estudios genéticos en trastornos del movimiento, ataxias y paraparesias [Internet]. Madrid: Sociedad Española de Neurología, Ediciones SEN; 2023. Disponible en: https://www.sen.es/pdf/2023/Manual_Genetica_TM.pdf
Novis LE, Spitz M, Jardim M, et al. Evidence and practices of the use of next generation sequencing in patients with undiagnosed autosomal dominant cerebellar ataxias: a review. Arq Neuropsiquiatr. 2020;78(9):576-85. doi:10.1590/0004-282x20200017
Cornejo-Olivas M, Bazalar-Montoya J. Advances in genetics and genomics in inherited neurological diseases in Peru. Rev Neuropsiquiatr. 2020;83(4):215-6. doi:10.20453/rnp.v83i4.3886
Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract. 2018;8(1):27-32. doi:10.1212/cpj.0000000000000421
Warner JP, Barron LH, Goudie D, et al. A general method for the detection of large GAG repeat expansions by fluorescent PCR. J Med Genet. 1996;33(12):1022-6. doi:10.1136/jmg.33.12.1022
Southern E. Southern blotting. Nat Protoc. 2006;1:518-25. doi:10.1038/nprot.2006.73
Chintalaphani SR, Pineda SS, Deveson IW, et al. An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathol Commun. 2021;9:98. doi:10.1186/s40478-021-01201-x
Krygier M, Mazurkiewicz-Bełdzińska M. Milestones in genetics of cerebellar ataxias. Neurogenetics. 2021;22:225-34. doi:10.1007/s10048-021-00656-3
Behjati S, Tarpey PS. What is next generation sequencing? Arch Dis Child Educ Pract Ed. 2013;98:236-8. doi:10.1136/archdischild-2013-304340
Papadopoulou E, Pepe G, Konitsiotis S, et al. The evolution of comprehensive genetic analysis in neurology: implications for precision medicine. J Neurol Sci. 2023;447:120609. doi:10.1016/j.jns.2023.120609
Quintáns B, Prieto MF, Carracedo A, et al. Asesoramiento genético en Neurología: un problema complejo que necesita regulación. Neurología. 2011;26(3):129-36. doi:10.1016/j.nrl.2010.09.010
Cornejo-Olivas M, Solis-Ponce L, Araujo-Aliaga I, et al. Machado Joseph-Disease is rare in the Peruvian population. Cerebellum. 2023;22:1192-9. doi:10.1007/s12311-022-01491-4
Mazzetti P, Inca-Martínez M, Tirado-Hurtado I, et al. Neurogenetics in Peru, example of translational research. Rev Peru Med Exp Salud Publica [Internet]. 2015;32(4):787-93. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342015000400023
Bazalar-Montoya J, Cornejo-Olivas M, Duenas-Roque MM, et al. Clinical genome sequencing in patients with suspected rare genetic disease in Peru. NPJ Genom Med. 2024;9(1):51. doi:10.1038/s41525-024-00434-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Andree Yerba-Coanqui, Jesús Gutierrez-Arratia , Elison Sarapura-Castro, Andrea Rivera-Valdivia , Maryenela Illanes-Manrique, Ismael Araujo-Aliaga, Ana Saldarriaga-Mayo, Richard S. Rodriguez , Mario Cornejo-Olivas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
RNP is distributed under a 